Press release
Antibody Purification Services Market to Reach USD 4.59 Billion by 2034
Antibody Purification Service
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72889
Advances in chromatography techniques, affinity resins, and high-throughput systems are driving efficiency and scalability. Additionally, the growing need for outsourcing by small- and mid-sized biotech firms, coupled with global expansion of biologics manufacturing, is fueling strong market growth.
In 2024, the global antibody purification services market is valued at USD 1.76 billion and is projected to reach USD 4.59 billion by 2034, growing at a CAGR of 9.9%.
Market Overview
• Market Size 2024: USD 1.76 billion
• Forecast 2034: USD 4.59 billion
• CAGR (2025-2034): 9.9%
Key Drivers
• Increasing demand for monoclonal antibodies and biosimilars.
• Expanding use of antibody-based diagnostics and research tools.
• Rising trend of outsourcing biologics R&D and production.
• Advances in chromatography and affinity purification technologies.
• Growth of CROs and CDMOs offering end-to-end biologics services.
Key Challenges
• High cost of purification technologies and services.
• Stringent regulatory requirements for therapeutic antibody production.
• Scalability challenges for novel antibody formats (bispecifics, fragments).
• Competition from in-house capabilities of large pharmaceutical firms.
Leading Players
Thermo Fisher Scientific, GE Healthcare (Cytiva), Merck KGaA, Sartorius AG, Bio-Rad Laboratories, Abcam, GenScript Biotech, Rockland Immunochemicals, WuXi Biologics, and Charles River Laboratories.
Segmentation Analysis
By Service Type
• Protein A/G/L Affinity Purification
• Ion Exchange Chromatography
• Size Exclusion Chromatography
• Mixed-Mode Chromatography
• Custom & Hybrid Purification Services
By Antibody Type
• Monoclonal Antibodies
• Polyclonal Antibodies
• Antibody Fragments & Bispecifics
By End User
• Biotechnology & Pharmaceutical Companies
• Academic & Research Institutes
• Contract Research Organizations (CROs)
• Diagnostic Companies
By Application
• Therapeutics Development
• Diagnostics
• Research & Drug Discovery
• Industrial Applications
Summary:
Monoclonal antibody purification dominates due to high therapeutic demand, while custom purification for bispecifics and antibody fragments is growing rapidly. Biotechnology and pharmaceutical companies are the primary end users, though CROs/CDMOs are playing an increasing role.
Explore Full Report here: https://exactitudeconsultancy.com/reports/72889/antibody-purification-services-market
Regional Analysis
• North America
The largest market, driven by the dominance of biologics R&D, presence of leading CROs/CDMOs, and regulatory support for antibody therapeutics.
• Europe
Strong adoption supported by established biotech clusters in Germany, Switzerland, and the UK. The EMA's focus on biologics further supports market growth.
• Asia-Pacific
Expected to record the fastest CAGR, driven by expanding biologics manufacturing in China, India, and South Korea, along with rising investments in antibody-based research.
• Middle East & Africa
Emerging opportunities with gradual expansion of biotech hubs and increasing academic collaborations.
• Latin America
Brazil and Mexico lead the region, with growing participation in biologics research and diagnostic antibody development.
Summary:
North America and Europe dominate today's antibody purification services market, while Asia-Pacific will grow fastest through 2034, fueled by biopharma outsourcing and expanding biologics production capacity.
Market Dynamics
Growth Drivers
1. Rising demand for therapeutic monoclonal antibodies and biosimilars.
2. Growing outsourcing of biologics research and production.
3. Technological advancements in purification processes.
4. Expansion of CROs/CDMOs providing end-to-end antibody services.
5. Increasing demand for antibody-based diagnostics.
Challenges
• High cost and complexity of purification workflows.
• Stringent regulatory oversight of therapeutic antibody quality.
• Difficulties in scaling purification for novel antibody constructs.
• Competition from in-house purification units of large pharma.
Latest Trends
• Adoption of continuous bioprocessing and single-use technologies.
• Development of high-capacity protein A resins for cost efficiency.
• Integration of AI-driven process optimization in antibody purification.
• Growing demand for customized purification services for novel antibody formats.
• Strategic collaborations between CROs, CDMOs, and biopharma firms.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72889
Competitor Analysis
Key Players
• Thermo Fisher Scientific
• GE Healthcare (Cytiva)
• Merck KGaA
• Sartorius AG
• Bio-Rad Laboratories
• Abcam
• GenScript Biotech
• Rockland Immunochemicals
• WuXi Biologics
• Charles River Laboratories
Competitive Landscape
The market is moderately consolidated, with major life sciences companies (Thermo Fisher, Cytiva, Merck, Sartorius) leading in chromatography and purification technologies. CROs and CDMOs like WuXi Biologics and Charles River are expanding global service offerings. Competition focuses on scalability, customization, and regulatory compliance.
Conclusion
The antibody purification services market is expanding rapidly, driven by rising demand for biologics, diagnostics, and research antibodies. Valued at USD 1.76 billion in 2024, the market is projected to reach USD 4.59 billion by 2034, growing at a CAGR of 9.9%.
Future opportunities lie in continuous bioprocessing, customized services for advanced antibody formats, and expansion in emerging markets. Companies that leverage cutting-edge purification technologies while offering scalable, regulatory-compliant services will lead in this growing biologics-focused sector.
This report is also available in the following languages : Japanese (抗体精製サービス), Korean (항체 정제 서비스), Chinese (抗体纯化服务), French (Services de purification d'anticorps), German (Antikörper-Reinigungsdienste), and Italian (Servizi di purificazione degli anticorpi), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/72889/antibody-purification-services-market#request-a-sample
Our More Reports:
Aseptic Filling Machine Market
https://exactitudeconsultancy.com/reports/73535/aseptic-filling-machine-market
Automated Cell Processing System Market
https://exactitudeconsultancy.com/reports/73536/automated-cell-processing-system-market
Non-Viral Transfection Reagents Market
https://exactitudeconsultancy.com/reports/73537/non-viral-transfection-reagents-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antibody Purification Services Market to Reach USD 4.59 Billion by 2034 here
News-ID: 4205697 • Views: …
More Releases from Exactitude Consultancy
Antisense Oligonucleotides Market to Reach USD 11.8 Billion by 2034
Antisense Oligonucleotides Market Outlook 2024-2034: Expanding Horizons in Genetic Medicine and Rare Disease Therapies
Introduction
Antisense oligonucleotides (ASOs) are short, synthetic nucleic acid strands designed to bind to RNA targets and regulate gene expression. They represent a breakthrough in precision medicine, with the ability to silence, modify, or correct genetic mutations at the RNA level. ASOs are already transforming treatment approaches for rare genetic disorders, neurodegenerative diseases, and certain cancers.
Download Full PDF…
Peptide Synthesis Market to Reach USD 6.4 Billion by 2034, Growing at 11.7% CAGR
Introduction
Peptides - short chains of amino acids - have emerged as critical tools in drug discovery, diagnostics, and therapeutic applications. Synthetic peptides are increasingly being used in oncology, metabolic diseases, infectious diseases, immunology, and neurology, while also playing a vital role in biomarker discovery and vaccine development.
With advancements in solid-phase peptide synthesis (SPPS), liquid-phase methods, and hybrid technologies, the market is expanding rapidly. Supported by growing demand for peptide-based drugs,…
MicroLED Photoluminescence Inspection System Market to Hit USD 692 Million by 20 …
MicroLED technology is widely regarded as the future of advanced display systems, offering superior brightness, energy efficiency, color accuracy, and lifespan compared to OLED and LCD technologies. However, one of the biggest challenges in scaling MicroLED for mass production lies in quality inspection, as millions of microscopic LEDs must be tested for uniformity and performance.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/75145
Photoluminescence (PL) inspection systems have emerged as…
Continuous Manufacturing Market to Reach USD 8.9 Billion by 2034, Growing at 12. …
Introduction
Continuous manufacturing (CM) is revolutionizing the pharmaceutical industry by replacing traditional batch processing with a streamlined, uninterrupted production process. Unlike batch manufacturing, where drugs are produced in discrete steps, continuous manufacturing integrates all processes - from raw material input to final dosage form - in a seamless, automated flow.
This approach offers significant advantages: improved efficiency, reduced costs, enhanced quality control, and faster time-to-market. With regulators such as the U.S. FDA…
More Releases for Antibody
Evolving Market Trends In The Antibody Drug Conjugates Industry: Regulation On A …
The Antibody Drug Conjugates Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Antibody Drug Conjugates Market Size During the Forecast Period?
The market size for antibody drug conjugates has experienced rapid expansion in the past few years. It's projected to rise from…
TIGIT Antibody Clinical Trials FDA Approval Market Size Anti TGIT Antibody Sales …
Anti TIGIT Antibodies Clinical Trials & Market Opportunity Outlook 2028 Report Highlights:
• Anti TIGIT Antibodies In Clinical Trials: > 50 Antibodies
• First Anti TIGIT Antibody To Get Approval Within Next 5 Years
• Global Anti TIGIT Antibodies Clinical Pipeline Insight By Company, Indication and Phase
• Insight On More Than 50 Anti TIGIT Antibodies In Clinical Trials
• Anti TIGIT Antibodies Market Trends by Indication & Country
• Global Anti TIGIT Antibodies Market Dynamics
Download Report:
https://www.kuickresearch.com/report-anti-tigit-antibody-anti-tigit-antibodies-fda-approved-tigit-antibody-tigit-inhibitors-tigit-drugs-approved-tigit-expression-tigit-ligand-tigit-gene
In recent years, the global…
Mammalian Polyclonal IgG Antibody Market, Mammalian Polyclonal IgG Antibody Mark …
"According to the research report, the global inspection machines market was valued at USD 845.21 million in 2022 and is expected to reach USD 1,437.59 million by 2032, to grow at a CAGR of 5.5% during the forecast period."
Request Our Free Sample Report for Inspection Machines Market Insights and Emerging Trends @ https://www.polarismarketresearch.com/industry-analysis/inspection-machines-market/request-for-sample
Report Overview
Polaris Market Research, a leading global market research and consulting company, has recently published its latest report…
Global Combination Antibody Therapy Market 2022: Antibody/Antibody Combination S …
The combination antibody therapy market is expected to experience significant growth in the coming years. Combination antibody therapy involves the use of two or more monoclonal antibodies (mAbs) in combination to treat various diseases, such as cancer, autoimmune disorders, and infectious diseases.
Request For Free Sample Report of "Combination Antibody Therapy Market"@ https://www.persistencemarketresearch.com/samples/11740
Combination antibody therapy has several potential benefits over single-agent therapies, including increased efficacy, improved patient outcomes, and reduced toxicity.…
Global Combination Antibody Therapy Market 2022: Antibody/Antibody Combination S …
Combination antibody therapy involves the use of two or more antibodies to target and treat a specific disease or condition. This type of therapy is often used in cancer treatment, as it can be more effective at targeting and killing cancer cells than single-antibody therapies. Combination antibody therapy can also be used to treat a range of other diseases and conditions, including autoimmune diseases, infectious diseases, and allergic conditions.
Request For…
Procalcitonin Antibody Market Report 2018: Segmentation by Type (Polyclonal Proc …
Global Procalcitonin Antibody market research report provides company profile for Ningbo Medicalsystem Biotechnology, Snibe, Vazyme Biotech, Getein Biotech, Hotgen Biotech, Lumigenex, Shanghai Medicine'nest Pharmaceutical, Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, Wondfo and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for…
